Decision Guidance Choose cagrilintide + retatrutide when you want maximum theoretical pathway coverage and you accept higher cost, complexity, and uncertainty
How to use it Liraglutide is FDA approved as adjunctive therapy to diet and exercise for weight management in adults with body mass index at or above 30 kg/m (or 27 kg/m with a weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia)
Reality : Wasted money and peptides
K., Rosenstock, J., Wadden, T
The most common question from patients considering GLP-1 therapy is which medication produces the best results
Ideally, look for products that are third-party tested to ensure purity and potency